Presentation is loading. Please wait.

Presentation is loading. Please wait.

Baldness reversed by chemotherapy

Published byEthan Woods Modified over 5 years ago

Similar presentations

Presentation on theme: "Baldness reversed by chemotherapy"— Presentation transcript:

1 Baldness reversed by chemotherapy
William Read, MD  Journal of the American Academy of Dermatology  Volume 63, Issue 4, Pages (October 2010) DOI: /j.jaad Copyright © 2010 American Academy of Dermatology, Inc. Terms and Conditions

2 Fig 1 Five months after stopping chemotherapy, there is new growth of red hair on the scalp. The slightly longer hair on the temples is changing from gray to red. Journal of the American Academy of Dermatology  , DOI: ( /j.jaad ) Copyright © 2010 American Academy of Dermatology, Inc. Terms and Conditions

3 Fig 2 The patient 10 years before undergoing chemotherapy. His scalp is bald and his hair is gray. Journal of the American Academy of Dermatology  , DOI: ( /j.jaad ) Copyright © 2010 American Academy of Dermatology, Inc. Terms and Conditions

Download ppt "Baldness reversed by chemotherapy"

Similar presentations

Tsung-Yu Tsai, MD, Yu-Chen Huang, MD 

Tsung-Yu Tsai, MD, Yu-Chen Huang, MD 
Lauren Kwa, BA, Jonathan I. Silverberg, MD, PhD, MPH 

Lauren Kwa, BA, Jonathan I. Silverberg, MD, PhD, MPH 
A girl with a solitary red bulla

A girl with a solitary red bulla
Dolphin-to-human transmission of lobomycosis?

Dolphin-to-human transmission of lobomycosis?
Facial adenocarcinoma treated with intra-arterial chemotherapy

Facial adenocarcinoma treated with intra-arterial chemotherapy
Repigmentation and new growth of hairs after anti–interleukin-17 therapy with secukinumab for psoriasis  Franco Rongioletti, MD, Cristina Mugheddu, MD,

Repigmentation and new growth of hairs after anti–interleukin-17 therapy with secukinumab for psoriasis  Franco Rongioletti, MD, Cristina Mugheddu, MD,
Yul W. Yang, MD, PhD, David J. DiCaudo, MD 

Yul W. Yang, MD, PhD, David J. DiCaudo, MD 
Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients  Lucy Y. Liu, BA, Brittany.

Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients  Lucy Y. Liu, BA, Brittany.
Daniel S. Winchester, MD, Thomas L. Hocker, MD, Randall K. Roenigk, MD 

Daniel S. Winchester, MD, Thomas L. Hocker, MD, Randall K. Roenigk, MD 
Megan Wood, MD, Tom Raisanen, MD, Ingrid Polcari, MD 

Megan Wood, MD, Tom Raisanen, MD, Ingrid Polcari, MD 
Array of cutaneous adverse effects associated with sorafenib

Array of cutaneous adverse effects associated with sorafenib
“Arrow” sign: A rapid microscopic diagnosis of hair change associated with epidermal growth factor receptor inhibitors  Pai-Shan Cheng, MD, Feng-Jie Lai,

“Arrow” sign: A rapid microscopic diagnosis of hair change associated with epidermal growth factor receptor inhibitors  Pai-Shan Cheng, MD, Feng-Jie Lai,
Elana Putterman, BS, Leslie Castelo-Soccio, MD, PhD 

Elana Putterman, BS, Leslie Castelo-Soccio, MD, PhD 
Sarah Sung, MD, Alexa B. Kimball, MD, MPH 

Sarah Sung, MD, Alexa B. Kimball, MD, MPH 
María Jesús Suárez Valladares, MD, Manuel Ángel Rodríguez Prieto, MD 

María Jesús Suárez Valladares, MD, Manuel Ángel Rodríguez Prieto, MD 
The impact of secukinumab treatment on the prevalence of human papillomavirus in patients with psoriasis: A pilot study  Hsien-Yi Chiu, MD, Tsen-Fang.

The impact of secukinumab treatment on the prevalence of human papillomavirus in patients with psoriasis: A pilot study  Hsien-Yi Chiu, MD, Tsen-Fang.
Permanent chemotherapy-induced alopecia: A review

Permanent chemotherapy-induced alopecia: A review
Clindamycin-induced Sweet syndrome

Clindamycin-induced Sweet syndrome
Ben Tallon, MBChB, Elizabeth Blanchard, MD, Lynne J. Goldberg, MD 

Ben Tallon, MBChB, Elizabeth Blanchard, MD, Lynne J. Goldberg, MD 
JAK inhibitors in dermatology: The promise of a new drug class

JAK inhibitors in dermatology: The promise of a new drug class

Similar presentations

Ads by Google